Christopher E. Kubasik, Chair and CEO, has demonstrated a clear selling bias in his transactions involving L3Harris Technologies (LHX), with $83.7 million in total sales compared to $23.5 million in purchases across 33 reported trades. His recent activity reinforces this trend, with six sales since November 2025 and no buys. Notably, Kubasik executed two major dispositions in 2025: a $23.2 million sale on September 12 and a $19.5 million sale on July 29, both accompanied by smaller derivative transactions. More recently, on February 24 and 26, 2026, he reported $2.1 million and $6.7 million in sales, respectively, under code "F" (indicating transactions involving family members or trusts). The only purchase in the dataset was a modest $333,462 acquisition on November 13, 2025, dwarfed by a $4.3 million sale the same day. While some transactions involved derivative securities (coded "M"), the overall pattern shows consistent monetization of LHX holdings, with the largest outright sales clustered in mid-to-late 2025 followed by continued but smaller disposals in early 2026. All activity remains confined to LHX, suggesting focused management of his position in this single security.
AI-assisted summary